101 related articles for article (PubMed ID: 101889)
1. The use of rigid analogues to probe hallucinogen receptors.
Nichols DE; Weintraub HJ; Pfister WR; Yim GK
NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
[No Abstract] [Full Text] [Related]
2. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
3. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
Nichols DE; Pfister WR; Yim GK
Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
[No Abstract] [Full Text] [Related]
4. Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats.
Rusterholz DB; Spratt JL; Long JP; Kelly TF
Life Sci; 1978 Oct; 23(14):1499-506. PubMed ID: 713706
[No Abstract] [Full Text] [Related]
5. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
6. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
[No Abstract] [Full Text] [Related]
7. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
8. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
9. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
[No Abstract] [Full Text] [Related]
10. Scratching response induced in mice by mescaline and related amphetamine derivatives.
Kulkarni AS
Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
[No Abstract] [Full Text] [Related]
11. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
Buyniski JP; Smith ML; Bierwagen ME
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
[No Abstract] [Full Text] [Related]
12. Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.
Andén NE; Corrodi H; Fuxe K; Meek JL
Eur J Pharmacol; 1974 Feb; 25(2):176-84. PubMed ID: 4435021
[No Abstract] [Full Text] [Related]
13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
[TBL] [Abstract][Full Text] [Related]
14. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
[TBL] [Abstract][Full Text] [Related]
15. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
[TBL] [Abstract][Full Text] [Related]
16. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
Otaka T
Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
[No Abstract] [Full Text] [Related]
17. Serotonin receptor involvement in an animal model of the acute effects of hallucinogens.
Geyer MA; Krebs KM
NIDA Res Monogr; 1994; 146():124-56. PubMed ID: 8742797
[No Abstract] [Full Text] [Related]
18. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
[No Abstract] [Full Text] [Related]
19. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
Nichols DE
J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
[No Abstract] [Full Text] [Related]
20. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
